Luisa Bellu

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Giuseppe Lombardi, Gian Luca De Salvo, Alba A. Brandes et al. · The Lancet Oncology · 2018 · 367 citations

Neuro-oncology, Medicine, Relapsed Glioblastoma +10

Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions

Anna Luisa Di Stefano, Alberto Pïcca, Édouard Saragoussi et al. · Neuro-Oncology · 2020 · 67 citations · Full text

Diagnostic Value of Plasma and Urinary 2-Hydroxyglutarate to Identify Patients With Isocitrate Dehydrogenase-Mutated Glioma

Giuseppe Lombardi, Giuseppe Corona, Luisa Bellu et al. · The Oncologist · 2015 · 62 citations · Full text

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)

Giuseppe Lombardi, Andrea Pace, Francesco Pasqualetti et al. · Journal of Neuro-Oncology · 2015 · 43 citations

Neuro-oncology, Glioma, Radiation Therapy +10

Validation of the Comprehensive Geriatric Assessment as a Predictor of Mortality in Elderly Glioblastoma Patients

Giuseppe Lombardi, Eleonora Bergo, Mario Caccese et al. · Cancers · 2019 · 35 citations · Full text